Gastric Cancer or Gastroesophageal Junction Adenocarcinoma Clinical Trials in Harbin, Heilongjiang

Oral Paclitaxel Plus Fruquintinib Verus Investigator's Choice in Second-Line Advanced Gastric Cancer